Condition
Pulmonary Vascular Disease
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 16 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
16 shownExercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung DiseasesNCT07777367 · 2026-10-01
RECRUITINGExercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)NCT07777445 · 2026-10-01
RECRUITINGContrast Echocardiography During Exercise to Assess Pulmonary Blood VolumeNCT06195059 · 2024-07-30
RECRUITINGPulmonary Hypertension in Left Heart DiseaseNCT05935605 · 2023-07-20
RECRUITINGPediatric Pulmonary Hypertension Network (PPHNet) Informatics RegistryNCT02249923 · 2014-10-01
RECRUITINGAssessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAHNCT07804576 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAHNCT07804693 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAHNCT07804524 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAHNCT07804472 · 2026-09-25
NOT_YET_RECRUITINGSleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAHNCT07801963 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAHNCT07801859 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAHNCT07797166 · 2026-09-25
NOT_YET_RECRUITINGHigh Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)NCT06092424 · 2023-09-23
UNKNOWNHigh Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)NCT06003244 · 2023-09-23
UNKNOWNHA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)NCT06072417 · 2023-09-22
UNKNOWNHA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)NCT05996302 · 2023-07-05
UNKNOWNCommon interventions
6-minute walk distance (6MWD) test on ambient conditionsOTHER26-minute walk distance (6MWD) test with supplemental oxygen (LOX)OTHER2Descent from 2850m to sea levelBEHAVIORAL2Re-Ascent from sea level to 2850mBEHAVIORAL26-minute walk distance (6MWD) testOTHER16-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)OTHER1Assessment without intervention at High altitudeOTHER1Descent and re-ascent (2850m, sea level)BEHAVIORAL1Descent to sea levelBEHAVIORAL1Lung ultrasoundDIAGNOSTIC_TEST1Re-Ascent sea level to 2850mBEHAVIORAL1Relocation from HA to LABEHAVIORAL1Relocation to sea levelBEHAVIORAL1Relocation to sea level for 2 daysOTHER1Transthoracic Echocardiography (TTE)DIAGNOSTIC_TEST1
Leading sponsors
Trial status mix
NOT_YET_RECRUITING7
RECRUITING5
UNKNOWN4
Phase mix
NA13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.